Deater Foundation, Inc.

Related HSAN1 Articles & Links:

Related Articles:	MGH Symposiums:
Garofolo et al. (2011) - Oral L-serine supplementation reduces production of neurotoxic dSLs in mice and humans with HSAN1 Rotthier et al. (2011) – Characterization of Two Mutations in SPTLC1 Subunit of SPT Associated with HSAN1 Rotthier et al. (2010) – Mutations in the SPTLC2 Subunit of SPT Cause HSAN1 Bertea et al. (2010) – DSBs as Plasma Markers in Diabetes Mellitus Penno et al. (2010) – HSAN1 is Caused by the Accumulation of Two Neurotoxic Sphingolipids Eichler et al. (2009) – Overexpression of WT SPT1 Lowers DSB Levels and Rescues Phenotype of HSAN1 McCampbell et al. (2005) – HSAN1 Mouse Model Bejaoui et al. (2001) - SPTLC1 is Mutated in HSAN1 Bejaoui et al. (1999) – Genetic Linkage of HSAN1 Tocantins & Reimann (1939) - Perforating Ulcer	2010 (February) HSAN1 Meeting (Boston, MA): Burns, Ellen - HSAN1 Meeting Report April 2008 Symposium: HSN1/HSAN1 Technical Symposium Report - Tami Murphy HSAN1 Symposium Report - Ellen Burns General Info - Schedule/Attendees
Additional Info:	Related Links:
Spring 2009 - Spring Progress Report 2009 - March 2009 Family Report (modified version) 2009 - Dr. Eichler's Spring Progress Report (technical) Overexpression of serine palmitoyltransferase...	Muscular Dystrophy Association